Navigation Links
Immucor and Alverno Clinical Laboratories Sign Five-Year Automation Agreement
Date:5/27/2009

NORCROSS, Ga., May 27 /PRNewswire-FirstCall/ -- Immucor, Inc. (Nasdaq: BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced today that it has signed a five-year agreement with Alverno Clinical Laboratories, LLC, one of the largest regional hospital laboratory integrated delivery systems in the nation, serving 27 hospitals in Illinois and Indiana.

Under the agreement, Alverno is standardizing pre-transfusion testing in 26 facilities with Immucor automation through the acquisition of 24 Echo instruments and 2 Capture Workstations. Additionally, Immucor will be the primary source for Alverno's blood bank reagent needs.

"We are pleased to partner with such an innovative organization as Alverno," stated Dr. Gioacchino De Chirico, President and Chief Executive Officer of Immucor. "We believe that integrated delivery networks can achieve significant benefits both in terms of improving operational efficiency and improving patient safety through standardizing their blood bank operations with Immucor automation."

"Our goal is to produce accurate and timely test results while implementing standardized best practices across all laboratory sites," stated Sam Terese, Chief Operating Officer of Alverno Clinical Laboratories. "We chose Immucor due to the exceptional functionality of the Echo instrument and its fit with LEAN operations as well as Immucor's commitment to improving transfusion medicine."

Immucor's innovative automation strategy provides scalable solutions to meet the needs of all blood banks, regardless of size. Immucor has continually invested in automation since 1998, most recently with the Echo instrument. The Echo, which is designed for smaller volume laboratories, features a broad test menu, instant access and the industry's f
'/>"/>

SOURCE Immucor, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Immucor Schedules Second Quarter Earnings Release and Conference Call
2. FDA Accepts Immucors Response to Warning Letter
3. Immucor Announces Fiscal Year 2009 Revenue and Earnings Guidance
4. Immucor CEOs Italian Trial Moves Toward Second Phase
5. Immucor To Acquire BioArray Solutions Ltd.
6. Immucor Responding to FTC Inquiry
7. Immucor Settles SEC Investigation
8. Clinical Data on Peregrines Bavituximab Cancer Program to Be Discussed in Two Presentations at 2009 ASCO Annual Meeting
9. Senesco Presents Pre-Clinical Multiple Myeloma Data at the 12th Annual Meeting of the American Society of Gene Therapy
10. Lexicon to Present Clinical Data for LX1031 and LX1032 at Digestive Disease Week
11. Medarex to Host Clinical Program Update Conference Call on Tuesday, June 2, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 2014 According to ... (Consumables, Instruments, Services), Methods (Phenotypic, Genotypic), Applications (Pharmaceutical, Diagnostic, ... Characterization) - Global Forecasts to 2019" published ... estimated at $896.5 Million in 2014 and ... 2019, growing at a CAGR of 5.9% ...
(Date:7/28/2014)...   Propeller Health , the FDA-cleared digital health ... Brad Towle as Senior Vice President, Business ... the company,s sales growth, customer acquisition and program expansion. ... his past role in the development of accountable care ... pivotal time in the industry," said David Van ...
(Date:7/28/2014)... The global market for biotechnology is expected ... a new study by Grand View Research, Inc. Increasing ... vaccines and drugs in an attempt to improve healthcare ... to drive market demand over the next six years. ... the use of genetically engineered seeds is expected to ...
(Date:7/28/2014)... DUBLIN , July 28, 2014 Research ... "Global Particle Size Analysis Market 2014-2018" report to their ... Particle size analysis is a technique used to determine ... powder or liquid. It is crucial to analyze the size ... material. Therefore, particle size analysis is performed to determine the ...
Breaking Biology Technology:Microbial Identification Market worth $1,194.1 Million by 2019 2Microbial Identification Market worth $1,194.1 Million by 2019 3Propeller Health Hires Brad Towle as Senior Vice President of Business and Client Development 2Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 2Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 3Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 4Global Particle Size Analysis Market 2014-2018 2
... 20, 2010 A pediatrician, nurses, and staff from ... at Berlin Elementary School on Monday, December 20th to ... to the student,s family. Magellan Biosciences has donated test ... II analyzers, which provide three-minute blood-lead results from a ...
... Technologies, Inc., a leading provider of software and services ... upcoming Web seminars to help existing and potential new ... to qualify for valuable Meaningful Use incentive dollars. ... Avatar™ 2011 electronic health record (EHR) software recently achieved ...
... InterMune, Inc. (Nasdaq: ITMN ) today ... for the commercialization of Esbriet™ (pirfenidone) in Europe.  InterMune,s ... CHMP opinion that is now awaiting ratification by the ... Officer and President of InterMune, said, "We are very ...
Cached Biology Technology:Whitney M. Young, Jr. Health Services and Magellan Biosciences Partner to Provide Three-Minute LeadCare II Blood-Lead Screenings to Berlin Elementary Students 2Whitney M. Young, Jr. Health Services and Magellan Biosciences Partner to Provide Three-Minute LeadCare II Blood-Lead Screenings to Berlin Elementary Students 3Whitney M. Young, Jr. Health Services and Magellan Biosciences Partner to Provide Three-Minute LeadCare II Blood-Lead Screenings to Berlin Elementary Students 4Whitney M. Young, Jr. Health Services and Magellan Biosciences Partner to Provide Three-Minute LeadCare II Blood-Lead Screenings to Berlin Elementary Students 5Netsmart Technologies to Host Valuable Meaningful Use Web Seminars 2Netsmart Technologies to Host Valuable Meaningful Use Web Seminars 3Netsmart Technologies to Host Valuable Meaningful Use Web Seminars 4InterMune Announces Senior Leadership Appointments to Prepare for Launch of Esbriet™ (Pirfenidone) in Europe 2InterMune Announces Senior Leadership Appointments to Prepare for Launch of Esbriet™ (Pirfenidone) in Europe 3InterMune Announces Senior Leadership Appointments to Prepare for Launch of Esbriet™ (Pirfenidone) in Europe 4InterMune Announces Senior Leadership Appointments to Prepare for Launch of Esbriet™ (Pirfenidone) in Europe 5InterMune Announces Senior Leadership Appointments to Prepare for Launch of Esbriet™ (Pirfenidone) in Europe 6
(Date:7/28/2014)... years ago, MIT professor John Essigmann and colleagues from the ... drug. They thought if they could induce the virus to ... die out a strategy that our immune system uses ... drug, which caused HIV to mutate at an enhanced rate, ... patients in a small clinical trial reported in 2011. In ...
(Date:7/28/2014)... other forms of dementia, but the research community is ... Washington bioengineers have a designed a peptide structure that ... proteins into a state that,s linked to widespread diseases ... and Lou Gehrig,s disease. The synthetic molecule blocks these ... an abnormally folded form by targeting a toxic intermediate ...
(Date:7/28/2014)... Rice University researchers are using magnetic beads and ... can be used as microscale models for polymer macromolecules. ... introduced as theory in the 1950s, can be made ... be of interest to materials scientists who study the ... Rice chemical and biomolecular engineer Sibani Lisa Biswal and ...
Breaking Biology News(10 mins):Forced mutations doom HIV 2Forced mutations doom HIV 3Forced mutations doom HIV 4New protein structure could help treat Alzheimer's, related diseases 2New protein structure could help treat Alzheimer's, related diseases 3Seeing is bead-lieving 2
... Baltimore, MDStem cells are the body,s primal cells, retaining ... of cells over many cycles of cell division. How ... have identified a gene, named scrawny, that appears to ... stem cells in their undifferentiated state. Understanding how stem ...
... long suffered an identity crisis. Pop culture heedlessly ... dinosaurs. Even paleontologists assumed that because the creatures flew, they ... legs to take flight. Now comes ... 500 pounds of reptilian heft into flight required pterosaurs to ...
... have discovered a new way for bacteria to transfer ... raises the unsettling possibility that bacterial swapping of toxins ... previously imagined. , In a laboratory experiment, the scientists ... a notorious bacterium that causes toxic shock syndrome and ...
Cached Biology News:'Scrawny' gene keeps stem cells healthy 2Four, three, two, one . . . pterosaurs have lift off 2NYU scientists discover dangerous new method for bacterial toxin transfer 2NYU scientists discover dangerous new method for bacterial toxin transfer 3NYU scientists discover dangerous new method for bacterial toxin transfer 4
... evolutionarily conserved form of cell suicide, which ... central component of this process is a ... These enzymes participate in a series of ... pro-apoptotic signals and result in the cleavage ...
...
...
Mouse monoclonal antibody raised against a partial recombinant ALAS2. NCBI Entrez Gene ID = ALAS2...
Biology Products: